Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × NETWORK × ixazomib × Clear all

Phase

Status

Terminated 1 Recruiting 1 Completed 1

Sponsor Class

OTHER 11 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Multiple Myeloma 1 Genetic Diseases, Inborn 1

Interventions

Radiotherapy 37 Cisplatin 30 Fluorouracil 15 Docetaxel 14 Paclitaxel 13 Doxorubicin 12 Carboplatin 12 Cyclophosphamide 11 Filgrastim 10 Methotrexate 9 Gemcitabine 9 Etoposide 9 Chemotherapy, Adjuvant 9 Capecitabine 9 Surgical Procedures, Operative 8 Oxaliplatin 8 Leucovorin 8 Vincristine 7 Peripheral Blood Stem Cell Transplantation 7 Radiotherapy, Conformal 6 Dexamethasone 6 Cetuximab 6 Prednisone 5 Neoadjuvant Therapy 5 Mitomycin 5 Ifosfamide 5 Fenretinide 5 Bevacizumab 5 Vinblastine 4 Topotecan 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03683277 2025-02-19

IFM2014-01

Intergroupe Francophone du Myelome

Phase 2 Terminated

Multiple Myeloma, Recurrence, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon ⚡